1. Akagi J, Hodge JW, McLaughlin JP, Gritz L, Mazzara G, Kufe D, Schlom J, Kantor JA (1997) Therapeutic antitumor response after immunization with an admixture of recombinant vaccinia viruses expressing a modified MUC1 gene and the murine T-cell costimulatory molecule B7. J Immunother 20: 38–47
2. Altevogt P, Michaelis M, Kyewski B (1989) Identical forms of the CD2 antigen expressed by mouse T and B lymphocytes. Eur J Immunol 19: 1509–1512
3. Anasetti C, Martin PJ, June CH, Hellstrom KE, Ledbetter JA, Rabinovitch PS, Morishita Y, Hellstrom I, Hansen JA (1987) Induction of calcium flux and enhancement of cytolytic activity in natural killer cells by cross-linking of the sheep erythrocyte binding protein (CD2) and the Fc-receptor (CD16). J Immunol 139: 1772–1779
4. Ayroldi E, Migliorati G, Cannarile L, Moraca R, Delfino DV, Riccardi C (1997) CD2 rescues T cells from T-cell receptor/CD3 apoptosis: a role for the Fas/Fas-L system. Blood 89: 3717–3726
5. Bei R, Kantor J, Kashmiri SV, Abrams S, Schlom J (1994) Enhanced immune responses and anti-tumor activity by baculovirus recombinant carcinoembryonic antigen ( CEA) in mice primed with the recombinant vaccinia CEA. J Immunother Emphasis Tumor Immunol 16: 275–282